Podcasts about Psoriasis

Do you feel like you get crazy histamine intolerance symptoms as your body reacts to everything — certain foods, smells, stress, or even the weather? Symptoms such as itchy skin, rashes, dermatographia, angioedema, bloating, or headaches that seem to appear out of nowhere are often linked to histamine intolerance.But before you blame your diet and dive headfirst into a low-histamine diet, know that food isn't likely to blame. After working with over 1,000 clients, I can tell you that there are deeper, more pressing issues that drive urticaria and chronic hives.Let's dive into why you probably don't have histamine intolerance (despite having all the symptoms), how histamine intolerance differs from MCAS, and what's really triggering these crazy histamine reactions. From mold exposure to liver detox issues and hormone imbalances, we explore how these hidden factors can lead to ongoing inflammation and itchy skin that just won't quit.⭐️Mentioned in This Episode:- FREE Root Cause Finder Guide - https://www.skinterrupt.com/rootcauseguide-pod - See all the references

Why does your dermatologist want you to throw out your doona immediately? Why do nurses desperately need you to stop lying about how that foreign object got stuck inside you? And, what is the real reason for your recurrent vaginal infections? In this episode, we speak to Rodney Sinclair, Professor of Dermatology at The University of Melbourne, to tackle the confusion between dermatitis, eczema and psoriasis. He explains the genetic origins of eczema, why most people stop their treatment too soon and he shares his theory on why your choice of bed cover might be aggravating your itchy skin. We cover everything from if it is really possible to “grow out” of eczema, the difference between treating a flare-up and maintaining remission and why five-minute lukewarm showers are a non-negotiable. Plus, Dr Mariam and Claire deliver a crucial PSA on behalf of nurses and doctors everywhere regarding foreign objects being put where the sun doesn’t shine. And, in our Quick Consult, Dr Mariam answers a frustrated listener’s question about recurrent thrush and Bacterial Vaginosis (BV) - and if their partner could be unknowingly reinfecting them…THE END BITS All your health information is in the Well Hub. Sign up to the Well Newsletter to receive your weekly dose of trusted health expertise without the medical jargon. Ask a question of our experts or share your story, feedback, or dilemma - you can send it anonymously here, email here or leave us a voice note here. Ask The Doc: Ask us a question in The Waiting Room. Follow us on Instagram and Tiktok. Support independent women’s media by becoming a Mamamia subscriber CREDITS Hosts: Claire Murphy and Dr Mariam Guest: Professor Rodney Sinclair Senior Producers: Claire Murphy and Sally Best Audio Producer: Scott Stronach Video Producer: Julian Rosario Social Producer: Elly Moore Mamamia acknowledges the Traditional Owners of the Land we have recorded this podcast on, the Gadigal people of the Eora Nation. We pay our respects to their Elders past and present, and extend that respect to all Aboriginal and Torres Strait Islander cultures.Information discussed in Well. is for education purposes only and is not intended to provide professional medical advice. Listeners should seek their own medical advice, specific to their circumstances, from their treating doctor or health care professional. +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++Support the show: https://www.mamamia.com.au/mplus/See omnystudio.com/listener for privacy information.

Description: Psoriatic disease affects far more than just the skin. Hear leading dermatologist Dr. April Armstrong and Dr. Benoît Guérrette discuss this and more with Jensen, a patient advocate. Psoriatic disease affects not only the skin but it can impact confidence, emotional and social well-being, and daily life. In this episode, join moderator Dr. Guy Eakin, Chief Scientific and Medical Officer at NPF, as we explore the disconnect between clinical classifications of psoriasis and what patients experience in real-life with leading dermatologist Dr. April Armstrong, Dr. Benoît Guérrette, Vice President of Dermatology & Rheumatology at Takeda, and Jensen, a NPF patient advocate and former Lead Youth Ambassador. Listen as we address the need for a more nuanced approach to classifying disease severity that accounts for the holistic needs of psoriatic disease, as well as share insights into how advocacy and awareness can drive change in treatment access and care standards.  The intent of this episode is to identify how clinical severity classifications of psoriasis are evolving to meet the needs of those who live with the disease and how that change impacts overall management. This episode is sponsored by Takeda. Timestamps: (0:00) Intro to Psoriasis Uncovered and guest welcome to dermatologist Dr. April Armstrong, Vice President of Takeda, Dr. Benoît Guérette, and patient advocate Jensen, who discuss the unmet needs of people with moderate psoriasis and how as a community we can better serve those living with the disease. 2:22 How health care providers and the biopharmaceutical industry are coming together to address systemic eligibility and the unmet needs of people living with psoriasis. 4:25 Quality of life should be included when assessing clinical severity in psoriasis and identification of appropriate treatment choices. 6:52 The impact of misdiagnosis, inappropriate treatment, and effect on high impact sites can be life- altering. 8:30 How appropriate treatment and knowledge can make all the difference when diagnosed with plaque psoriasis.  9:40 Views on the psoriasis disease classification system and how it's evolving to include real life impact from physical and emotional needs, to more personalized care for those living with psoriasis, even when small body surface areas are involved. Severity isn't defined by skin coverage alone. 12:38 What's needed to prioritize the care and outcomes of people living with psoriasis. 14:18  The future of management and care for psoriatic disease. 15:53  "My skin tells a story." Wisdom from what I wish I had known previously. 16:52  Moving closer to care that truly reflects the lives and needs of those who live with psoriasis. Key Takeaways: ·       Severity of psoriasis isn't defined by skin coverage or body surface area (BSA) alone. The impact on quality of life should also be considered in the assessment, selection of treatment, and management of the disease.  ·       The psoriasis disease classification system is evolving to be more of a patient centered approach.  Many clinicians are now using the International Psoriasis Council (IPC) or 2 bucket approach to identify whether someone should receive a topical or systemic treatment based on location and response to treatment, as well as impact on quality of life.  ·       With continued research and  development, the next 5 to 10 years could see a shift in effective treatment options while also treating sooner to initiate better outcomes for people living with psoriasis and psoriatic arthritis. Guest Bios:   April Armstrong, M.D., M.P.H. is an internationally renowned dermatologist and clinical researcher who is a Professor and Chief of Dermatology at the University of California Los Angeles (UCLA) where she specializes in inflammatory skin diseases such as psoriasis, atopic dermatitis, and hidradenitis suppurativa (HS). Dr. Armstrong is also the Co-Director for Network Resources at the UCLA Clinical and Translational Research Institute. She has conducted over 150 clinical trials and published over 350 high impact articles in scientific journals. Dr. Armstrong holds multiple leadership positions including the immediate Past Chair of the National Psoriasis Foundation Medical Board, Co-President of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), councilor for the International Psoriasis Council, and board member for the International Dermatology Outcome Measures and the American Academy of Dermatology.  Benoît Guérette, Ph.D. is an accomplished leader in medical affairs with extensive experience across academia and the pharmaceutical industry. Since March 2025, Dr. Guérette has served as Vice President of Dermatology and Rheumatology US Medical Affairs at Takeda Pharmaceutical. Prior to joining Takeda, he held several strategic and leadership roles at various pharmaceutical companies, including overseeing clinical development, global and U.S. medical affairs, global access & pricing, translational sciences and more. Before transitioning to the industry, Dr. Guérette was an Associate Professor of Immunology at Laval University, leading research in cancer immunology. He holds a Ph.D. in Medicine, Microbiology, and Immunology from Laval University and completed postdoctoral studies in Inflammation and Immunology at  Harvard Medical School.  Jensen is a volunteer and former Lead Youth Ambassador for the National Psoriasis Foundation. Jensen developed psoriasis at age 7 but wasn't formally diagnosed until age 14 being misdiagnosed along the way, trying different management approaches that were ineffective. She was a competitive swimmer from elementary through high school and in the last 2 years of high school played lacrosse. Upon finishing high school she attended college becoming a registered nurse in an intensive care unit. Jensen wants "youth living with psoriatic disease to feel a  community that is behind them and with them every step of the way. I really want to be able to make a difference in a way that would've helped me as a child when I was diagnosed." Resources: Ø  "Reassessing Psoriasis Severity" Advance Online, National Psoriasis Foundation. H. Onorati. January 16, 2024,  https://www.psoriasis.org/advance/psoriasis-severity-high-impact-sites/   Ø  "Psoriasis Involving Special Areas is Associated with Worse Quality of Life, Depression, and Limitations in the Ability to Participate in Social Roles and Activities". Blauvelt, A., Strober, B., Gondo, G., Journal of Psoriasis and Psoriatic Arthritis Volume 8, Issue 3.  https://journals.sagepub.com/doi/full/10.1177/24755303231160683

Have you struggled with unexplained redness, irritation, flare-ups, or changes in your skin as an adult? In this episode, dermatologist Dr Angela Tewari breaks down the real differences between eczema, psoriasis, and rosacea. How each condition works beneath the surface, why they show up differently, and what they reveal about your overall skin health. You'll learn what defines a truly healthy skin barrier, the early signs of imbalance, and why chronic skin conditions are becoming increasingly common in our 30s, 40s, and 50s.We also explore the powerful connection between your skin, immune system, gut health, stress, and lifestyle, because real healing requires more than topical treatments. From dermatology-approved treatments to holistic tools like ceramides, probiotics, vitamin D, omega-3s, anti-inflammatory nutrition, and gentle skincare routines, this episode gives you a realistic roadmap for reducing flare-ups and rebuilding a resilient skin barrier.01:00 — Differences Between Eczema, Psoriasis & Rosacea05:15 — What Healthy Skin Really Looks Like & Early Signs of Inflammation07:30 — Why More Adults Are Developing Skin Issues10:00 — Eczema: Causes, Triggers & Treatment Options19:20 — Psoriasis: Immune Activation & Lifestyle Factors25:00 — Rosacea: Types, Triggers & Effective Treatments30:00 — Skin Care Essentials for Sensitive & Inflamed Skin32:15 — Key Nutrients & Supplements for Skin HealthRESOURCES: Grab all the links and resources mentioned in this episode at https://www.nicolegoodehealth.com/the-goode-health-podcast/episode-105DISCLAIMER: The content in this podcast and related website is not intended to be a substitute for medical advice. It is not intended to be used to diagnose or treat, instead it is designed to help educate and inspire. Always seek the advice of a professional medical practitioner or qualified health practitioner. Never ignore or disregard advice given to you based on information in this podcast or related website and do not delay in seeking medical advice.

The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects.  Features Dr. Jack Cush, Editor at RheumNow.com.  SHOW NOTES 1. Retrospective study of 39 pts w/ MDA5 + DM-ILD Rx w baricitinib. 31 (79.5%) had improvement in Gottron's, heliotrope, dyspnea, HRCT score, ferritin, LDH, steroid dose & 6 mo survival (87% vs. 70%, p = 0.047). https://t.co/RCTbBsCkeV 2. Pulse Steroids and Mycophenolate in Juvenile Dermatomyositis JAMA Dermatology has published a pilot study demonstrating the safety and efficacy of intermittent intravenous methylprednisolone pulse (IVMP) therapy plus mycophenolate in 28 patients with JDM. https://t.co/i2HBycbWY9 3. Myelodysplastic & chr myelomonocytic leukemia pts rarely get lupus. Review of 19 w/ SLE & 5 w/ CLE; these were older (65 yrs), more male (15M/9F), w/ less renal [10%] & articular [36%] Dz w/ less dsDNA [32%]. Thought to be clonal inflammatory, & not autoinflammatory, process. https://t.co/EAvkJm6GQs 4. Serious infections w/ adalimumab. Marketscan MarketScan claims study (1/17-12/20) of ADA Rx in Hidradenitis Supprativa (n 1650) or psoriasis(8699). Risk of SIE & hospitalization greater w/ HS (HR 1.53); esp for sepsis & GU infxnhttps://t.co/2qa7O2v6fm 5. No risk of MACE seen w/ initiation of IL-17(R)A inhib. French study of 34 241 ipts Rx IL-17(R)Ai and 381 MACEs. MACE risk was not elevated (OR, 1.25 [95% CI, 0.75-2.08] vs TNF-α inhibitors. https://t.co/WcjgRhr8mj 6. Genetic Risks and Severe Cutaneous Reactions to Allopurinol A matched cohort study shows that HLA-B*58:01 and HLA-A*34:02 are strongly associated with allopurinol-induced severe cutaneous adverse reactions (SCARs), these alleles were absent in more than one-third of those https://t.co/NLpHVhr9Ww 7. Western Australia study of 1854 SLE pts (median 40 yrs old). Interstitial lung disease was seen in in 3.8% of SLE, 26 fold more than controls. Risk factors for ILD included older age, smoking and serositis. SLE-ILD pts had higher mortality rates (MR 52.0, CI 37.0–71.1). 8. 25-Hydroxyvitamin D levels and Lupus Outcomes Lupus patients entering a prospective cohort study with low vitamin D levels faced doubled all-cause mortality risk and tripled risk for major cardiovascular events during follow-up averaging 6 years, researchers said. https://t.co/CYwVy7ls7y 9. ACR2025 Non-Renal Lupus Guidelines – from ACR Convergence 2025 10. 900,000 vs 9 It takes about 900,000 minutes to become a board-certified dermatologist. At that point, you might be very skilled and well-informed. It takes less than nine minutes to make your patient feel seen, understood and reassured. If you skip the 9 minutes, you wasted the 900,000  https://t.co/o7BaWjS4HB

Send us a textDermatologist and clinical researcher Dr. Michael Bernhardt joins Dr. Erich Schramm to unpack the rapidly evolving science of atopic dermatitis. The two doctors discuss the symptoms, science, and treatments for atopic dermatitis, including how much clinical research has changed the landscape and improved outcomes. The two get into how the immune system drives the disease, and how new therapeutic drugs target those systems in way thats more than just skin deep.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

CME credits: 0.25 Valid until: 26-11-2026 Claim your CME credit at https://reachmd.com/programs/cme/a-clear-horizon-in-plaque-psoriasis-an-update-on-investigational-oral-therapies/37867/ Among patients with moderate to severe plaque psoriasis, oral formulations of therapies is often a preferred route of administration, particularly among those with a fear of needles, which can negatively impact patent compliance. However, the currently available oral small-molecule therapies apremilast and deucravacitinib have demonstrated lower levels of skin clearance relative to biologics for the treatment of plaque psoriasis. Investigation into novel oral small-molecule therapies is ongoing, such as next-generation TYK2 inhibitors and the first-in-class investigational targeted oral peptide icotrokinra, which selectively targets IL-23 receptor signaling. These therapies have demonstrated dramatically improved clinical responses versus comparators and may significantly impact the current treatment paradigm for plaque psoriasis. =

Is it just an eczema (atopic dermatitis) flare or could it be something else? Most people don't realize that Staph aureus could be the hidden skin flare trigger that actively weakens your skin barrier, triggering more inflammation, itchiness, and persistent eczema symptoms. Even if it seems “normal,” the presence of Staph might point to deeper imbalances that need attention.In this episode, we dig into how Staph aureus, the gut microbiome, environmental toxins, and even air pollution can all contribute to recurring eczema.Joining me is Dr. Peter Lio, a board-certified dermatologist and respected voice in integrative dermatology. He's a Clinical Assistant Professor at Northwestern University and has authored over 100 papers, along with a textbook on Integrative Dermatology.If you're ready to understand why your eczema isn't clearing up, this is a must-listen conversation filled with insight and practical takeaways.⭐️Mentioned in This Episode:- Learn how to address your Eczema root causes

In this Bestie Advice episode, we dive into the raw reality of living with psoriasis and other skin conditions: the shame, the insecurity, and the urge to hide when you don’t feel comfortable in your own skin. We unpack how physical struggles can take a toll on self-worth, intimacy, and confidence, and share advice on navigating the emotional weight of it all while finding ways to reclaim your power.See omnystudio.com/listener for privacy information.

Please visit answersincme.com/860/100752367-replay to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in the management of psoriatic disease discuss challenges in treatment, emerging TYK2 inhibitor therapies, and evidence-based strategies to optimize patient care. Upon completion of this activity, participants should be better able to: Recognize how nurse practitioners and physician associates can help address barriers to care and enhance outcomes for patients with moderate to severe plaque psoriasis; Differentiate TYK2 signaling from JAK pathways and explain the relevance of these distinctions in clinical outcomes; Evaluate the impact of emerging data on TYK2 inhibitors in shaping therapeutic strategies for psoriatic disease; and Apply strategies for aligning TYK2 inhibitor therapy with patient needs and multidisciplinary care plans.

Please visit answersincme.com/860/100752367-replay to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in the management of psoriatic disease discuss challenges in treatment, emerging TYK2 inhibitor therapies, and evidence-based strategies to optimize patient care. Upon completion of this activity, participants should be better able to: Recognize how nurse practitioners and physician associates can help address barriers to care and enhance outcomes for patients with moderate to severe plaque psoriasis; Differentiate TYK2 signaling from JAK pathways and explain the relevance of these distinctions in clinical outcomes; Evaluate the impact of emerging data on TYK2 inhibitors in shaping therapeutic strategies for psoriatic disease; and Apply strategies for aligning TYK2 inhibitor therapy with patient needs and multidisciplinary care plans.

https://wels2.blob.core.windows.net/daily-devotions/20251119dev.mp3 Listen to Devotion [God will] give relief to you who are troubled. 2 Thessalonians 1:7 Relief Relief is big business. Walk up and down the aisles of your local pharmacy and read the labels. Relief from back pain. Relief from knee pain. Cold and flu relief. Relief from a toothache. Itch relief. Psoriasis relief. Earache relief. Headache relief. Sunburn relief. Foot pain relief. Relief from overworked muscles. All these types of relief are wonderful blessings from a gracious God. But in our Bible reading today, the apostle Paul speaks to us about a kind of relief that’s on an entirely different plane. It is the relief that the Lord promises to give to us on the Last Day, the day of judgment. As our Savior-God watches over us, he never forgets that every moment of every day you, and I are laboring under the weight of living in a sinful, fallen creation. Day by day, we do battle. We battle Satan—both his temptations and his accusations. We battle temptations and distractions from the world. And we do battle with our own sinful selves. All this he sees. All this he understands. And to encourage us to keep fighting the good fight of the faith, he promises to bring us sweet relief on the Last Day—a relief from all the troubles of this world, a relief beyond description. Author J.R. Tolkien was a Christian, and he once remarked that there are Christian themes in his great work, The Lord of the Rings. In a closing scene to the 2003 film based on Tolkien’s book, we see two individuals. The first is Frodo, a person who has just finished an exhausting, perilous journey to help defeat a great evil. As Frodo awakens from a long, deep sleep, he sees Gandalf, an old, dear friend he’d thought was long dead. Frodo and Gandalf look at each other, smile, and begin to laugh. And laugh. And laugh some more. The laughter is not only of joy and reunion. It is the laughter of indescribable relief. Such relief is what awaits us. And it’s the kind of relief that will never end. Prayer: Lord Jesus, because of you, a great, eternal relief awaits me. Move me never to forget this. Amen. Daily Devotions is brought to you by WELS. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. All Scripture quotations, unless otherwise indicated, are taken from the Holy Bible, New International Version®, NIV®. Copyright ©1973, 1978, 1984, 2011 by Biblica, Inc. ™ Used by permission of Zondervan. All rights reserved worldwide.

Join our Patreon for bonus episodes with more mold resources!Ever wondered why some people get sick in a moldy house and others don't?In this episode, I'm joined by Gracie Sanchez, a registered dietitian and one of our one-on-one practitioners here at Hormone Healing RD. Gracie's known as our resident mold expert, her own experience with repeated exposures and years of functional training have given her a grounded, compassionate approach that takes the fear out of mold illness.We unpack what mold actually is, how it affects the body, and why it's showing up for so many women today. There are hidden ways it grows, reasons you can't “detox” while you're still living in it, and simple ways to make your home less mold-friendly. Because sometimes the smartest move isn't adding another supplement, it's changing the environment your body's trying to heal in.This is a part 1 of a 2-part video series where Gracie and I cover everything about mold and how to prevent it.You'll Learn:[00:00] Introduction[01:13] The early signs of mold exposure that first showed up in Gracie's college dorm[02:48] How mercury fillings, fertility struggles, and fatigue pointed toward deeper mold issues[06:06] The surprising barrier she faced as an RD trying to get mold training, and what changed everything[10:05] What mold actually is, and the three ways it spreads and harms the body[16:28] Why mold illness can look like “random” health issues from sinus infections to hormone chaos[20:39] How humidity, darkness, and even dust create the perfect environment for mold to thrive[31:24] The reason you can't detox mold while you're still living in it, and what happens if you try[36:40] Practical ways to prevent mold in everyday life, from humidity monitors to open windowsResources Mentioned:Dr. Jill Crista Mold Training Certification | CourseIntellipure Air Purifier | WebsiteAirfree Air Purifier | WebsiteIQAir Air Purifier | WebsiteThermoPro Humidity Meter | WebsiteThe Feminine Periodical Newsletter | WebsiteYou can work 1:1 with Gracie here.Master your minerals. Harmonize your hormones. Start your mineral journey here.Find more from Amanda:Hormone Healing RD | InstagramHormone Healing RD | WebsiteHormone Healing RD | FacebookHormone Healing RD | YouTubeHormone Healing RD | TikTok

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I'm a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Dr. Warrick Bishop hosts a podcast episode with Fiona Foo, a cardiologist, and Dr. Smith, a dermatologist, discussing the connection between psoriasis and cardiovascular health. Psoriasis, affecting 2-4% of the population, is a chronic inflammatory skin condition that can lead to systemic inflammation impacting organs like the heart, joints, and liver. Patients with psoriasis have an increased risk of heart attacks and strokes due to elevated cardiovascular risk factors and inflammation.

If mealtimes with your child have become a daily battle, you're not alone. Picky eating isn't always just a phase, and unfortunately many of the tactics that your parents used on you (like “You can't leave the table until you clean your plate”) often backfire. In this episode, I am joined by Alyssa Miller, RD, a picky eating specialist, to explore the real reasons that drive picky eating in toddlers and young children, including underlying gut issues and nutrient deficiencies. So if you're looking to get your child to eat more foods, and make mealtime peaceful again, Alyssa is here to help you find practical strategies to make your picky eater feel safe trying new foods without pressure, bribing, or giving in. ⭐️Mentioned in This Episode:- Join Alyssa's Free workshop to stop picky eating

Joel Gelfand, MD, MSCE, FAAD interviewed by Sanna Ronkainen, MD, FAAD

At just 15, Maya's body felt ancient—crippled by sudden arthritis, back pain, and joint stiffness. In this raw moment, she reveals the shock of waking up unable to move, and how it marked the beginning of her search for healing beyond conventional medicine.⏱️ Timestamps – “I Woke Up in an 80-Year-Old Body”00:46 – Isolation & Cravings Shift 02:11 – Meet Maya & Carrie 03:31 – COVID, Sports & Sudden Pain 05:01 – Medical Mystery & Sacroiliac Pain 06:31 – Carrie's Transformation & 50 lb Weight Loss 08:01 – Tracking, Data & Keto Shift 09:31 – Bodybuilding Past & Intermittent Fasting 11:01 – Maya's Influences: Jordan & Mikhaila Peterson 12:31 – Electrolytes & Mood Struggles 14:01 – Genetic Arthritis & Humira Experience 15:31 – Diet vs Medication: Choosing Carnivore 17:01 – Cultural Pressures in Japan 18:31 – Carrie's Maintenance & Dairy Challenge 20:01 – Fat vs Protein: Lifting & Satiety 21:31 – Skin, Psoriasis & Animal Fat Wins 23:01 – Japan Recap & Host Family Pressures 24:31 – Mental Health & Gen Z Epidemic 26:01 – Medical System & Carnivore Skepticism 27:31 – Sharing Stories & Facing Backlash 29:01 – Final Reflections & Empowerment Connect more with Dr. Kiltz:Website :https://www.doctorkiltz.com/Linktr.ee: https://linktr.ee/doctorkiltz?utm_source=linktree_profile_share<sid=f819f43c-43e2-45fe-ab8b-1c0af1962e2bKiltz's Mighty Tribe - Free membership and 30 Day Course:https://kiltz-mighty-tribe.mn.co/users/onboarding/choose_plan?plan_id=2184624&bundle_token=51d89e16bf2d37b1bb9945184e6b3256&prefer_signup=true&utm_source=manualKiltz Cups :https://kiltzcups.com/Doctor Kiltz Nutritional Solutions https://www.doctorkiltznutritionalsolutions.com/Instagram https://www.instagram.com/doctorkiltz/Tik tok:https://www.tiktok.com/@doctorkiltzFacebook:https://www.facebook.com/doctorkiltzAmazonhttps://www.amazon.com/Robert-Kiltz/e/B005EIXDWU%3Fref=dbs_a_mng_rwt_scns_shareBooks by Dr.Kiltzhttps://www.doctorkiltz.com/books-by-dr-kiltz/

Please visit answersincme.com/860/99505211-replay1 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in psoriasis discuss real‑world strategies for using oral small molecules in moderate to severe disease. Upon completion of this activity, participants should be better able to: Identify patients with moderate to severe plaque psoriasis who would benefit from oral small molecule therapy; Differentiate the targets/mechanisms of action of available oral small molecule therapy for moderate to severe plaque psoriasis; and Integrate strategies to individualize oral small molecule therapy for moderate to severe plaque psoriasis, while balancing safety, considering regional barriers.

Please visit answersincme.com/860/99505211-replay1 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in psoriasis discuss real‑world strategies for using oral small molecules in moderate to severe disease. Upon completion of this activity, participants should be better able to: Identify patients with moderate to severe plaque psoriasis who would benefit from oral small molecule therapy; Differentiate the targets/mechanisms of action of available oral small molecule therapy for moderate to severe plaque psoriasis; and Integrate strategies to individualize oral small molecule therapy for moderate to severe plaque psoriasis, while balancing safety, considering regional barriers.

Episode 70: What Your Skin Is Trying to Tell You — Healing Acne, Eczema & Psoriasis from WithinYour skin is more than just what you see in the mirror — it's your body's messenger.In this episode of Connecting with the Thom's, we unpack the deeper story behind acne, psoriasis, and eczema through the lens of biological medicine and emotional healing.Rather than seeing skin issues as something to suppress or “fix,” we explore how the skin acts as a primary emunctory (body block) — a pathway your body uses to eliminate toxins, emotions, and inflammation when other systems are overloaded.We cover:

TSW—Topical Steroid Withdrawal—when you're hooked on steroid creams for a skin condition and can't get off; Can diet, supplements, or Traditional Chinese Medicine help eczema? Strange bedfellows—when your hospital assigns you a homicidal roommate; Every step you take may reduce your risk of dying; Vitamin D and Omega-3 supplements reduce risk of autoimmune conditions; How long to curtail fish oil before a medical procedure or surgery? Supplements for neuropathy.

Episode 205: Atopic Dermatitis Kara Willbanks (medical student) explains the definition, pathophysiology, and treatment of eczema. Dr. Arreaza adds some input about bleach baths and topical steroids. Written by Kara Willbanks, MSIV, American University of the Caribbean. Comments and edits by Hector Arreaza, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.October is the Eczema Awareness Month!What Is Atopic Dermatitis? Atopic dermatitis, a form of eczema, is a chronic, relapsing inflammatory skin disorder that often begins in childhood but can affect people of all ages. Other eczematous dermatoses include seborrheic dermatitis, contact dermatitis, juvenile plantar dermatosis, and stasis dermatitis. Atopic dermatitis is one of the most common skin conditions in the developed world, typically affecting up to 20% of children and 5-10% of adults. Patients usually present with severe pruritus (itchiness) and dry, inflamed patches of skin. Common sites include the face and extensor surfaces in infants, and flexural areas — like the elbows and knees — in older children and adults. Atopic dermatitis is often associated with other allergic conditions like asthma and allergic rhinitis — what we call the “atopic triad.” These conditions should also be considered when diagnosing someone with atopic dermatitis. PathophysiologyAtopic dermatitis is believed to occur due to a combination of genetic, immune, and environmental factors. A major component is a defective skin barrier, often linked to mutations in the filaggrin gene. This allows irritants, allergens, and microbes to penetrate the skin more easily, triggering inflammation.Differential DiagnosisAtopic dermatitis can sometimes mimic other skin conditions, so it's important to keep a differential in mind: -Contact dermatitis – triggered by allergens or irritants; often limited to the area of exposure but also tends to be very itchy. -Seborrheic dermatitis – greasy scales, typically on the scalp, eyebrows, and nasolabial folds -Psoriasis – well-demarcated plaques with silvery scales; sometimes found in similar areas of the body as eczema. -Tinea (fungal infections) – ring-shaped lesions with active, scaly borders -Important to note that treatment of tinea with topical steroids can make the rash much worse. -Scabies – intense itching, especially at night, with burrows between fingers. Ruling out these conditions helps guide the right treatment and prevent chronic mismanagement. As a recap our main differential diagnosis: contact dermatitis, seborrheic dermatitis, psoriasis, tinea, and scabies.The treatment cornerstone: Moisturizers The most important daily treatment for atopic dermatitis is regular moisturizing. Moisturizers repair the skin barrier, reduce water loss, and protect against irritants. They should be applied at least twice daily, ideally right after bathing while the skin is still damp (within 3 minutes is most ideal). Use greasy ointments or thick creams rather than lotions — think products with ceramides or glycerin (hydrates and protects skin). It is best to choose ointments or creams without additives, perfumes or fragrances. Greasier ointments are the preferred vessel; however, patient compliance may be less as they may be unpleasant to some.Bleach Baths For patients with frequent skin infections or severe eczema, dilute bleach baths can be a game-changer. How to do it? Use ¼ to ½ cup of household bleach in a full standard bathtub of water (about 40 gallons) and soak for 10 minutes, twice a week. This helps reduce bacterial colonization — particularly Staphylococcus aureus — which commonly worsens eczema. After the bath, pat the skin dry and immediately apply a moisturizer (within 3 minutes). Bleach baths are endorsed by the American Academy of Pediatrics and the American Academy of Dermatology as an adjunctive treatment for atopic dermatitis, especially in patients with moderate to severe disease and frequent bacterial infections, but the evidence for their efficacy is mixed, and further well-designed studies are needed.Medical Treatments-Topical corticosteroids: When moisturizers alone aren't enough, we move to anti-inflammatory therapy. Topical corticosteroids are the first-line treatment for flares. Some studies suggest that a short burst of a high-potency topical corticosteroid to rapidly control active disease, followed by a quick taper in potency, is most effective, whereas others use the lowest-potency agent thought to be needed and adjust upward only if this fails. Common steroids used are hydrocortisone (low potency), triamcinolone (medium potency), or betamethasone (high potency). -High-potency steroids should never be applied to sensitive skin like the face. With short-term use of lower-potency steroids, there is a low likelihood of skin atrophy but use for more than 6 months is linked with greater levels of skin thinning -Wet wrap therapy: Wet wrap therapy improves absorption of topic steroid. Apply a topical steroid, then layer a wet dressing and then a dry dressing over the top of that. This can be beneficial in providing  both relief of symptoms and prevention of itching. In pediatric patients it is called “daddy's socks therapy” because large socks may be used to cover the arms of kids.-Topical calcineurin inhibitors — like tacrolimus — are great alternatives for sensitive areas or for maintenance once inflammation is under control. They may burn upon application which can scare patients away from their use.-PO antihistamines can help with itching, especially at night, but they don't treat inflammation itself.-Systemic therapies, like dupilumab (Dupixent®), an IL-4 receptor antagonist, are reserved for moderate to severe cases unresponsive to topical therapy. This is a great time to refer to your local dermatologist for management! Many of the newer treatments are highly effective but can require more frequent monitoring.Recent Research One recent study is the 2024 Cochrane network meta-analysis comparing effectiveness of topical anti-inflammatory treatments for eczema that was recently published in the AFP Journal in July of 2025.Here are the highlights:-Over 291 RCTs with ~45,846 participants were included. -The analysis ranked potent topical corticosteroids, JAK inhibitors (for example ruxolitinib (Opzelura® 1.5 %), and tacrolimus 0.1 % among the most effective for reducing signs and symptoms of eczema. -In contrast, PDE-4 inhibitors [like crisaborole (Eucrisa®) 2 %] were among the least effective in this comparison. -Regarding side effects: tacrolimus and crisaborole were more likely to cause burning or stinging at the application site; corticosteroids were less likely in the short term to cause local irritation.-Long-term outcomes regarding effectiveness or safety of treatments for eczema were not addressed by the review because they are rarely reported.”-Another insight from this study is considering cost when initiating treatment. Most topical steroids are significantly more cost effective than JAK inhibitors or calcineurin inhibitors so it may be best to start with a cheaper solution in an uninsured patient considering their relative effectiveness. Additional Tips & Lifestyle -Keep baths and showers short and in lukewarm water.-Avoid harsh soaps and detergents — use gentle, fragrance-free cleansers.-Wear soft cotton clothing instead of wool or synthetics.-Identify and avoid triggers — common ones include stress, sweating, allergens, and certain foods (especially in kids).-Ice packs can help reduce itching and relieve any burning sensation.-Keep fingernails short, especially in children, help cause less trauma to the skin from repeated itching. Living with eczema Many celebrities like Kerry Washington, Jessica Simpson, Kelly Rowland, Brad Pitt and Kristen Bell have spoken out about their lives with eczema. They have shared personal stories about how they were diagnosed, what treatment works for them, and the general impact it has had on their lives and mental health. I feel like it can be so important for celebrities to speak out about their lives with certain conditions because it helps to normalize the condition, raise awareness of the struggles, and encourages more open dialogue.It is important to remember that for patients living with eczema, the persistent itch-scratch cycle can be very distressing, causing patients to struggle with their sleep and day-to-day activities. Anxiety and depression are common in patients with eczema so as physicians it is vital to monitor for signs of distress. Support groups can be incredibly helpful for patients [National Eczema Association]If you are interested in providing additional information to your patients or getting this for yourself, you can find more resources on altogethereczema.org or nationaleczema.org. Key Takeaways Atopic dermatitis is chronic but manageable. Moisturizers are the foundation of treatment. Topical steroids and calcineurin inhibitors control inflammation. Bleach baths help reduce bacterial load and flare severity. Always rule out other skin conditions to ensure appropriate management. Atopic dermatitis can be managed by the primary care physician but in certain cases (cases refractory to standard topical treatment, recurrent infections, etc.), a referral to dermatology can be especially helpful.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! References:Coping with eczema. Allergy & Asthma Network. (2025, May 20). https://allergyasthmanetwork.org/what-is-eczema/coping-with-eczema/.Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014 Feb;70(2):338-51. doi: 10.1016/j.jaad.2013.10.010. Epub 2013 Nov 27. PMID: 24290431; PMCID: PMC4410183. https://pubmed.ncbi.nlm.nih.gov/24290431/.Yancey, J. R., & Green, S. (2025, July 15). Effectiveness of topical anti-inflammatory drugs for eczema. American Family Physician. https://www.aafp.org/pubs/afp/issues/2025/0700/cochrane-eczema.html.Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SMF865. CME/MOC/NCPD/AAPA/IPCE credit will be available until October 7, 2026.Elevating Psoriasis and Comorbidity Management With TYK2 Inhibition: Achieving and Sustaining Outcomes to Transform Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SMF865. CME/MOC/NCPD/AAPA/IPCE credit will be available until October 7, 2026.Elevating Psoriasis and Comorbidity Management With TYK2 Inhibition: Achieving and Sustaining Outcomes to Transform Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SMF865. CME/MOC/NCPD/AAPA/IPCE credit will be available until October 7, 2026.Elevating Psoriasis and Comorbidity Management With TYK2 Inhibition: Achieving and Sustaining Outcomes to Transform Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SMF865. CME/MOC/NCPD/AAPA/IPCE credit will be available until October 7, 2026.Elevating Psoriasis and Comorbidity Management With TYK2 Inhibition: Achieving and Sustaining Outcomes to Transform Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SMF865. CME/MOC/NCPD/AAPA/IPCE credit will be available until October 7, 2026.Elevating Psoriasis and Comorbidity Management With TYK2 Inhibition: Achieving and Sustaining Outcomes to Transform Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SMF865. CME/MOC/NCPD/AAPA/IPCE credit will be available until October 7, 2026.Elevating Psoriasis and Comorbidity Management With TYK2 Inhibition: Achieving and Sustaining Outcomes to Transform Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an educational grant from Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

Are oxalates really the villain in your diet that they're made out to be?If you've dealt with kidney stones or spiraled down a health forum rabbit hole, you've probably heard that a high oxalate diet is responsible for joint pain, leaky gut + chronic skin problems. But does cutting out high oxalate foods truly fix the problem—or is it just part of the story?In this episode, we're unpacking what oxalates really are, why your levels might be high (spoiler: it's not always your diet), best tests for oxalates, strategies to lower oxalates (beyond just eating low oxalate foods), and the deeper root causes of high oxalates that most people miss—like candida overgrowth, gut imbalances, and even heavy metals.Confused by the oxalate fear-mongering? You won't be after this.⭐️Mentioned in This Episode:- See all the references

Description: In this episode, we'll explore what it means to aim for no compromise in psoriatic arthritis care—addressing both skin and joint symptoms with dermatologist and rheumatologist Dr. Saakshi Khattri and patient advocate Dayna Pham who lives with psoriasis and psoriatic arthritis.   Join moderator Jeff Brown as he asks how patients and their healthcare providers can work in partnership to create a comprehensive, personalized treatment plan that reflects the full impact of psoriatic disease with triple board-certified dermatologist, rheumatologist, and internist Dr Saakshi Khattri, who is also an NPF medical board member, along with Dayna Pham, a patient advocate and volunteer with NPF's advocacy and community engagement teams who is living with psoriasis and psoriatic arthritis. . Whether you're newly diagnosed or navigating long-term care, this conversation is all about advocating for care that supports your whole self—without settling for less.   The intent of this episode is to emphasize the need to be aware of psoriatic arthritis symptoms and once symptoms are present accept no compromise when treating skin and joints to obtain clear skin and painless joints.  This podcast episode is sponsored by UCB. Timestamps: (0:23) Intro to Psoriasis Uncovered and guest welcome dermatologist, rheumatologist, and internist Dr. Saakshi Khattri and Dayna Pham, a patient advocate and medical student living with plaque psoriasis and psoriatic arthritis. (1:38) Psoriasis is more than skin deep with an inflammatory connection between the skin and joints. (3:03) The onset of psoriatic arthritis can be confusing. Healthy skin and joints should be the expectation without having to compromise on life's goals. (4:16) Knowing the association between psoriasis and psoriatic arthritis from the beginning is important to avoid delay in diagnosis and treatment. Be aware of systemic symptoms and discuss risks with a health care provider. (6:18 ) The goal of treatment is to achieve meaningful and lasting improvement in skin and joint symptoms.   (7:56) Treatments have evolved to target known drivers of inflammation in psoriasis and psoriatic arthritis. (8:29) The IL-17 family is a key cytokine with 6 related signaling molecules. IL-17A and F play a role in the inflammatory process related to psoriasis and psoriatic arthritis. (9:48) What discussion about treatment goals could include between a patient and health care provider. (13:19) If you have psoriasis and psoriatic arthritis you should feel empowered to speak up, seek answers, and find a treatment that offers no compromise on achieving clear skin and healthy joints.   Key Takeaways: ·       Psoriasis is an immune mediated disease that results in systemic inflammation that can affect        both the skin and joints. Unfortunately many people do not realize their joint symptoms may          be related to their psoriasis.  ·       The purpose of treatment which uses a variety of mechanisms of action targeting specific cytokines such as TNF-alpha, IL-12/23, IL-23, IL-17 is to achieve meaningful and lasting improvement in skin and joint symptoms. ·       If you have psoriasis and psoriatic arthritis you should feel empowered to speak up, seek answers, and to work with your health care team to identify goals and treatment choices that aim to preserve quality of life. Guest Bios:   Saakshi Khattri, M.D., MAS, is a triple board certified medical dermatologist, rheumatologist, and internist in the greater New York area who serves on the medical board of the National Psoriasis Foundation. She is the Director of the Center for Connective Tissue Diseases at Icahn School of Medicine at Mount Sinai. Dr. Khattri's area of interests include inflammatory and autoimmune skin diseases especially those with a rheumatology/dermatology overlap like psoriasis and psoriatic arthritis.  She is actively involved in research and clinical trials for psoriasis and psoriatic arthritis where she seeks to identify immune pathways that lead to new biomarkers and treatments. Dr. Khattri is extensively published  in peer reviewed journals and is also a member of the International Psoriasis Council.                                                                                                                                                                  ​Dayna Pham is  a patient advocate, medical student, and volunteer with NPF's advocacy and community engagement teams who lives with psoriasis and psoriatic arthritis. Dayna's psoriasis journey began at age 21 when she discovered bumps on her back which became plaques. Within weeks her body was impacted head to toe with plaque psoriasis, at 40% BSA.  After being misdiagnosed and undertreated for a few months she eventually found a dermatologist who diagnosed her with moderate-to-severe plaque psoriasis and prescribed a biologic. She's 25 now and seeks to live her fullest life possible while balancing her psoriasis and psoriatic arthritis. Resources: ·     Learn more about psoriatic arthritis from symptoms, diagnosis, treatment options to      coping with the disease. Ø  ·      Armstrong A, Levit NA, Schneider B, et al. Patient-identified treatment goals for psoriatic                 disease: Results from a US patient survey.  J Psoriasis Psoriatic Arthritis. 2025;10(1):1–11.    

In today's narration of Reddit stories, OP's good friend asked her to hide her psoriasis with body makeup to be maid of honor in her wedding.0:00 Intro0:19 Story 12:29 Story 1 Comments / OP's Replies6:10 Story 1 update11:18 Story 213:42 Story 2 Comments / OP's Replies18:47 Story 2 Update 120:09 Story 2 Update 221:08 Story 2 Update 321:26 Story 2 Comments / OP's RepliesFor more viral Reddit stories, incredible confessions, and the best Reddit tales from across the platform, subscribe to the channel! I *try* :) to bring you the most entertaining Reddit stories, carefully selected from top subreddits and narrated for your enjoyment. Whether you love drama, revenge, or heartwarming moments, this channel delivers the most captivating Reddit content. New videos uploaded daily featuring the best Reddit stories you won't want to miss!#redditupdate #redditrelationship #redditstoriesreddit Hosted on Acast. See acast.com/privacy for more information.

Description: Listen as NPF Medical Board Members, dermatologist Dr. Robert Kalb and rheumatologist Dr. Sergio Schwartzman discuss the connections between psoriasis and psoriatic arthritis, from cytokines to triggers, current and future treatments.   Join moderator Alan Simmons as he gains insights on what connects psoriasis and psoriatic arthritis with leading experts in psoriatic disease and NPF Medical Board members, dermatologist Dr. Robert Kalb with Buffalo Medical Group Dermatology, and rheumatologist Dr. Sergio Schwartzman from Schwartzman Rheumatology, as they discuss the known drivers of psoriasis and psoriatic arthritis, common triggers, benefits of targeted treatments, remission of disease, and upcoming treatment trends. The intent of this episode is to identify potential connections between psoriasis and psoriatic arthritis, and how targeted treatments have changed the outlook for management of psoriatic disease. This episode is sponsored by Novartis. Timestamps: (0:41) Intro to Psoriasis Uncovered and guest welcome dermatologist Dr. Robert Kalb and rheumatologist Dr. Sergio Schwartzman who are both involved in clinical care and research of psoriasis and psoriatic arthritis.  (1:15) Current known pro-inflammatory cytokines and cells found in psoriasis and psoriatic arthritis.   (5:33) Types of psoriasis that may lead to a higher risk of developing psoriatic arthritis. (9:33) Common triggers for psoriasis and psoriatic arthritis that could cause flares of the disease. (12:59) Key factors that are considered when choosing a treatment plan for any individual with psoriatic arthritis and psoriasis. (18:04) What treatment remission means for psoriasis. (19:36) Use of minimal disease activity (MDA) in psoriatic arthritis and what it means. (22:14) How a better understanding of the disease has led to more effective treatment choices and what choices are used by Dr. Kalb and Dr. Schwartzman for the management of psoriasis and psoriatic arthritis. (28:39) New developments in treatment and research in psoriatic arthritis and psoriasis. (36:01) Given treatment advancements it's a wonderful time to treat psoriatic disease. 3 Key Takeaways: ·       Cytokines are chemicals in the body that moderate various processes. In psoriasis and psoriatic arthritis,  an unknown trigger stimulates some cells to overproduce pro-inflammatory cytokines such as TNF-alpha, IL-17 or IL-23 leading to the development of skin and joint disease.  ·       Treating psoriasis and psoriatic arthritis helps move the body towards normalizing the over reactive immune system especially with more targeted treatments that safely and effectively block specific cytokines without affecting other organ systems.  ·       Given advancements in targeted treatments the goal is to reach and maintain remission of psoriatic disease. Guest Bios:   Leading dermatologist Robert Kalb, M.D. is the Chair of the Buffalo Medical Group Dermatology Department and the Director of the Buffalo Medical Group Phototherapy Center, one of the leading centers for psoriasis care in Western New York. He is also a Clinical Professor of Dermatology at the State University of New York at Buffalo School of Medicine and Biomedical Sciences (SUNY Buffalo), as well as an Adjunct Professor of Dermatology at the Perelman School of Medicine at the University of Pennsylvania where he plays a significant role in medical education, mentoring both medical students and dermatology residents. Dr. Kalb has extensive experience managing psoriasis, atopic dermatitis, and other inflammatory skin diseases. He has authored 70+ publications and is actively involved in clinical research, particularly focused on new treatment options for psoriasis. He is a member of the NPF Medical Board, American Academy of Dermatology, and is a member of the International Psoriasis Council.  Sergio Schwartzman, MD, is a world-renowned rheumatologist based in New York City who brings almost 40 years of experience and personalized clinical care for those who have psoriatic disease. Along with being in private practice at Schwartzman Rheumatology, Dr. Schwartzman is a Clinical Associate Professor of Medicine at Weill Cornell Medical College of Cornell University, the New York-Presbyterian Hospital, and the Hospital for Special Surgery in New York City where he has played a role in educating medical students, residents, fellows, and peers in rheumatology. Additionally, Dr. Schwartzman is the emeritus Franchellie M. Cadwell Clinical Associate Professor at the Hospital for Special Surgery. Dr. Schwartzman's current research interests include psoriatic arthritis, the spondyloarthritis group of diseases, ankylosing spondylitis, rheumatoid arthritis, as well as defining and treating autoimmune diseases of the eye. He has authored, co-authored, and edited over 150 papers, abstracts, books and book chapters on topics including psoriatic arthritis, ankylosing spondylitis, axial spondylarthritis, rheumatoid arthritis, lupus, autoimmune eye disorders, and other rheumatological and autoimmune conditions. He is a member of the NPF Medical Board. He is also a member of the American College of Rheumatology, the Association for Research in Vision and Ophthalmology, the Spondyloarthritis Research and Treatment Network (SPARTAN), the American Uveitis Society, and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Resources: Ø  “Redefining Remission. A new definition for patients, providers, and payers.” Advance Online, National Psoriasis Foundation. S. Schlosser. July 14, 2025.   Ø  Treatment and Management of Psoriasis     Ø  Treatment and Management of Psoriatic Arthritis  

Rob Stuart is a health coach specializing in skin health including eczema, psoriasis, dermatitis and rosacea. He's a gentleman and an absolute wealth of knowledge when it comes to topics like gut health, detoxification, physique optimization, fasting, enemas and MORE.  In this second of a two-part episode we focus mainly on •The Spiritual Aspect Of Healing •Finding Your Optimal Nutrition and Why Minimal Body Fast May Not Work For You •Healthy Bulking Get a ton of valuable information and Join Dry Fasting With Friends Jan 8th-12th by clicking here - https://dryfastwithfriends.com/ Follow me on Instagram here - https://www.instagram.com/realseanmccormick/ Learn more about my Coaching and Sign up for What's Up Wednesday Newsletter here -  https://seanmccormick.com/

DERM on RheumNow PODCAST (October 2025) Skin important Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects. Features Dr. Jack Cush, Editor at RheumNow.com.  SHOW NOTES 1. Skin Biopsies to Predict Scleroderma Outcomes?  2. Fibromyalgia in PsO & PsA is linked to greater treatment complexity and shorter biologic therapy survival. Retro matched 1:4 cohort study 61K PsO& 244K controls. FM prevalence 3.3% (OR 1.45). In PsA w/ FM, req more biologics w/ decr biologic survival (6 vs 10yrs) w/ incr switching (HR 1.82) https://buff.ly/TCc6Kc8 3. Guselkumab FDA Approved for Pediatric Psoriasis and Psoriatic Arthritis  https://rheumnow.com/news/guselkumab-fda-approved-pediatric-psoriasis-and-psoriatic-arthritis    4. Sonelokimab (SLK) is a nanobody that inhibits IL-17 A&F. Phase 2 ARGO trial 207 active PsA pts Rx w/ SLK 120-mg or 60-mg q4wks or PBO or adalimumab. ACR50 at wk 12 was 60-mg WI=46%; 120-mg WI=46%; PBO 20%. PASI90: 60mg 77% vs 120mg 59% vs PBO 15% https://t.co/ra0NqvUEru https://t.co/FXT6kkXUzH   5. Turkish study of 799 psoriasis pts - 30% had concurrent onset PsO & PsA & in 70% there was a long transition time (~13 yrs) from PsO-to-PsA. Factors assoc w/ prolonged interval included Depression, fatigue, scalp PsO(OR 7), nail PsO (3.2), +Fhx & enthesitis ever (OR 2) https://t.co/wqtSbeQ2vz 6. Mediterranean Diet Efficacy in Psoriasis   7. Gender Complexities in Psoriatic Arthritis Treatment Outcomes

What if the real game-changer for your gut and skin health isn't probiotics or diet… and is even BETTER than colostrum?In this episode, I'm joined by Brian Kaufman to explore how a colostrum-free immunoglobulin binder can target gut toxins, support gut repair (especially if you've got leaky gut), and calm inflammation — perfect for those struggling with chronic gut and skin issues as well as food sensitivities.If you've felt stuck and reactive to more and more foods, this could be the missing link!⭐️Mentioned in This Episode:- Get my fav dairy-free IgGs to boost your gut protocol

Episode Description:  Not sure if you should receive a vaccine given your psoriasis or psoriatic arthritis medication?  Dermatologist Dr. Jason Hawkes explores this question along with vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis. Listen as hosts Jeff Brown and LB Herbert discuss key questions about vaccine use and psoriatic disease with dermatologist and NPF Medical Board member Dr. Jason Hawkes who is co-owner, Chief Scientific Officer, and investigator with the Oregon Medical Research Center. Hear what the difference is between live and non-live vaccines, how type of vaccine and immunosuppressive medications impact the timing of vaccines in relation to treatment half-lives. Get your questions answered. The intent of this episode is to offer answers to questions about vaccine use for people with psoriasis and psoriatic arthritis who take immunosuppressive treatments.   Timestamps: (0:23) Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. Jason Hawkes. (1:15) In general, what is a vaccine and how it works in the body. (2:08) Will vaccines provide the same level of protection in people with psoriatic disease who are         on treatments that influence the immune system. (4:53) The difference between live and non-live vaccines.   (8:57) Summary of NPF Vaccine Recommendations in relation to live and non-live vaccines and             specific medications for psoriatic disease, including a definition of medication half-lives. (13:38) Vaccines that may be recommended prior to starting a systemic medication or biologic. (18:27) The mRNA vaccine – how it works in comparison to other vaccines. (22:31) How long immunity lasts from childhood vaccines. (25:24) The vaccine guidelines apply to both psoriasis and psoriatic arthritis with some nuances.      (28:38) Which healthcare provider to turn to for advice about vaccines and why. (31:54) Questions to ask your health care provider about vaccines. (33:26) How clinical trials and registries are evolving to assess the effect of vaccines with specific             medications and the need for greater understanding. (36:44) Develop a good relationship with your health care provider and don't be afraid to ask                 questions about your psoriatic disease, vaccines, or specific medications. Key Takeaways: ·       Vaccines work to help protect the body or stimulate protection against common infections or pathogens. There are different types that can be classified as either live or non-live vaccines.   ·       Evidence-based vaccine recommendations are available for people with psoriasis and psoriatic arthritis to help guide timing of when to receive live and non-live vaccines when taking immunosuppressive oral systemic medications and/or biologics.   ·       It's important to discuss which vaccines to consider, and how current psoriasis medication could impact the intended response and timing  with your health care team which includes a primary care physician, a dermatologist, and/or rheumatologist.    Guest Bio: Dermatologist Jason Hawkes, M.D., MS is Co-owner, Chief Scientific Officer and Investigator with Oregon Medical Research Center (OMRC) in Portland, Oregon. He is also a Clinical Assistant Professor of Dermatology at Oregon Health and Science University and the President and Sole Member of Hawkes Dermatology. Prior to joining the Oregon Medical Research Center, Dr. Hawkes held academic faculty appointments in the Departments of Dermatology at the University of Utah School of Medicine, Icahn School of Medicine at Mount Sinai, and University of California-Davis. Dr. Hawkes' principal clinical and research interests are the treatment of complex inflammatory skin diseases, such as psoriasis, hidradenitis suppurativa, chronic urticaria (hives), and eczema. He has a special interest in translational human research and the development of novel biologics and small molecules used for the treatment of inflammatory conditions. Dr. Hawkes is also a Councilor of the International Psoriasis Council (IPC) and serves on the Medical Board and Scientific Advisory Committee of the National Psoriasis Foundation (NPF) where he participates in the development of clinical consensus statements. Resources:         “Does Having Psoriatic Disease Impact Vaccine Choices?” Psound Bytes™ podcast with Dr. Sandy Chat (University of California) and Dr. Christoph Ellebrecht (Dept. of Dermatology, University of Pennsylvania).       Medical Board Clinical Statements                

Rob Stuart is a health coach specializing in skin health including eczema, psoriasis, dermatitis and rosacea. He's a gentleman and an absolute wealth of knowledge when it comes to topics like gut health, detoxification, physique optimization, fasting, enemas and MORE.  In this first of a two-part episode we focus mainly on •Animal based diets •Dry Fasting •The connection between health and spiritual growth Get a ton of valuable information and Join Dry Fasting With Friends Jan 8th-12th by clicking here - https://dryfastwithfriends.com/ Follow me on Instagram here - https://www.instagram.com/realseanmccormick/ Learn more about my Coaching and Sign up for What's Up Wednesday Newsletter here -  https://seanmccormick.com/  

Could your fatigue, bloating, or random skin rashes be more than “just stress” or IBS? You might be shocked to learn they could actually be signs of inflammatory bowel disease (IBD) or even colon cancer — yes, it's possible without having obvious digestive symptoms.It's unfortunately common to discover that you have Crohn's or ulcerative colitis in your 60s, and not because of gut issues… but during a routine colonoscopy screening. Others are misdiagnosed for years while battling brain fog, thyroid problems, skin issues like psoriasis, vitiligo, eczema, or even unexplained anemia — all while the real problem quietly worsens.I'm joined by Dr. Ilana Gurevich, a naturopathic gastroenterologist who specializes in complex GI disorders. We dive into the hidden signs of IBD, how it differs from IBS, sneaky signs of colon cancer (especially with skyrocketing rates), and the TRUTH about colonoscopies – why you should absolutely stop putting it off and never use a stool test for gut health as a replacement.If you've been brushed off, gaslit, or still searching for answers, you don't want to miss this.⭐️Mentioned in This Episode:- See all the references

Episode Description:  Listen as Kim Beer, Senior Vice President of Policy and External Affairs with the National Health Council, and Dermatologist, Dr. Jeffrey Cohen discuss the 2025 Medicare changes in relation to psoriatic disease and what's to come in 2026 with Jason Harris, Vice President of Government Relations and Advocacy at NPF.  Join this discussion about what changes occurred with Medicare in 2025 that impact psoriatic disease care, outcomes to date, what's to come in 2026, and what you should consider when choosing health care plans during open enrollment with Kim Beer, Senior Vice President of Policy and External Affairs with the National Health Council, Dermatologist, Dr. Jeffrey Cohen, Director of the Psoriasis Treatment Program at Yale University School of Medicine, and Jason Harris, Vice President of Government Relations and Advocacy at NPF.  The intent of this episode is to increase knowledge of the 2025 Medicare changes, what's to come, and how such changes impact psoriatic disease from coverage of prescriptions to overall health care. This episode is sponsored by Novartis. Timestamps:   (0:24) Intro to Psoriasis Uncovered and guest welcome Kim Beer, Senior Vice President of Policy   and External Affairs with the National Health Council, and Dermatologist, Dr. Jeffrey Cohen, Director of the Psoriasis Treatment Program at Yale School of Medicine. (2:25) Perspectives on current health care coverage in Medicare.    (5:14) Biggest changes to Medicare in 2025. (6:36) What is the Medicare Prescription Payment Plan and price negotiation for specific medications. (8:22) Challenges associated with the 2025 Medicare changes from a physician's perspective. (13:10) Price negotiation process via CMS  (Centers for Medicare and Medicaid Services) with the first 10 drugs price effective in 2026.   (17:52) Plan ahead and what to anticipate when choosing the right Medicare plan. (20:04) What the National Health Council and other patient advocacy organizations are doing to assess the impact of the CMS changes and identify steps for moving forward. (21:49) Medicare changes for 2026 that affect deductibles for health care services, prescription drug coverage, and vaccinations. (28:38) Potential assistance options for people who have Medicare insurance. (31:32) The role of patients in providing feedback on policy changes. (33:45) Changing from a commercial insurance plan to a Medicare Plan and what to think about when viewing plan options during the open enrollment period. (37:07) Be part of the process – let your voice be heard by sharing your experiences to help effect change. 3 Key Takeaways: ·       There are four key parts to Medicare health insurance (Part A, B, C and D) which underwent changes in 2025 including a payment cap for prescriptions and availability of a 12 month Prescription Payment Plan to opt in for medications. Additional changes are coming in 2026 including enactment of a price negotiated list of 10 medications. ·       The impact of such changes are both positive (better predictability and affordability) yet also reactionary. Such changes and potential impact should be considered when identifying plan coverage for health care and prescriptions during the open enrollment Medicare period of October 15 to December 7th.   ·       Be involved by telling your story about the impact of Medicare changes and find a trusted health care provider who is willing to work with you to identify an effective treatment plan that aligns with your health care needs and coverage. Guest Bios:   Dermatologist Jeffrey Cohen, M.D., MPH, is the Director of the Psoriasis Treatment Program and the Director of Safety with the Department of Dermatology at Yale University School of Medicine where he is also an Associate Professor of Dermatology and Biomedical Informatics and Data Science. Dr. Cohen treats a variety of skin conditions with a special interest in diseases of the immune system such as psoriasis and eczema tailoring treatments for each individual. He is the author of over 150 peer-reviewed articles on psoriasis and other topics in dermatology. Dr. Cohen serves on the Editorial Board of the Journal of the American Academy of Dermatology, is a Senior Editor for NPF's professional journal for health care providers Journal of Psoriasis and Psoriatic Arthritis, is a Councilor of the International Psoriasis Council, and serves on the Medical Board of the National Psoriasis Foundation.  Kimberly (Kim) Beer is Senior Vice President of Policy and External Affairs at the National Health Council (NHC) of which the National Psoriasis Foundation is a member. Kim leads strategic policy initiative and advocacy efforts to improve the lives of individuals with chronic conditions and disabilities. As a member of the NHC's executive leadership team, she helps to ensure access to high-quality, affordable healthcare for all Americans which includes advocating for policy and health care benefits within Medicare. Resources: For more reources and information about Medicare Contact the Patient Navigation Center to learn more about Medicare, find a health care provider, learn about treatments, or programs that may lower costs.   

Episode 25:41 The (Natural) Autoimmune Solution It is estimated that nearly 50 million Americans suffer with an autoimmune disorder. Conditions such as Hashimoto's, Crohn's, Ulcerative Colitis, Multiple Sclerosis, Type 1 Diabetes, Rheumatoid Arthritis, Psoriasis and Vitiligo.  The cause, according to the medical profession, is unknown. I don't believe that. The treatment, according to the medical profession, focuses on drugs. Drugs such as Immunosuppressants, Anti-Inflammatories, Corticosteroids, and Pain killers. I don't agree with that. The mechanism of action is that the Immune System starts attacking healthy cells. I don't think that's correct. So, what do I think? THAT is what this episode is all about. The cause, treatment and mechanism of action regarding autoimmune disorders. It's an episode that will certainly ruffle some feathers while also shedding some light on an interesting subject. Be sure to give it a good listen… especially if you, or someone you know, suffers with an autoimmune disorder.  And, as always, please share it with a friend.  Thanks!  ———————- Want to learn more? Continue the conversation regarding this episode, and all future episodes, by signing up for our daily emails. Simply visit: GetHealthyAlabama.com  Once there, download the “Symptom Survey” and you will automatically added to our email list. ———————- Also, if you haven't already, we'd appreciate it if you'd subscribe to the podcast, leave a comment and give us a rating. (Thanks!!!)                

 * This podcast is for informational and educational purposes only. It is not intended to diagnose or treat any disease. Please consult with your health care provider before making any health-related changes.

Modern dermatology is failing patients because the toolbox hasn't changed in decades: antibiotics, steroid creams, and ointments. These approaches may calm the surface symptoms, but they do nothing to address what's really going on underneath the skin (the root drivers of your condition.) That's why this episode matters. We dig into the real causes of eczema, psoriasis, and acne and more importantly, the science-backed solutions that actually correct the problem at its source.  These aren't just band-aids for symptom management. They're pathways to true, lasting healing.   TOPICS DISCUSSED IN THIS EPISODE: The failures of modern dermatology relying on drugs An intergrative approach to skin health (diet, lifestyle, probitoics and gut health) The causes, genetic markers and solutions of eczema, psoriasis and acne The skin-gut connection Environmental triggers for your skin (micorplastics, pesticides, mold and early choldhood edvelopment) Parasites and heavy metals as it relates to skin issues Symptom suppression and gaslighting that your doctor does for you skin issues The future of skin care and healing skin conditions    More from Dr. Partha Nandi Website: codexlabscorp.com Codex Labs on Amazon: amazon.com/stores/CodexLabs Instagram: @codexlabs     Leave us a Review: https://www.reversablepod.com/review   Need help with your gut? Visit my website gutsolution.ca to join a program: Get help now   Contact us: reversablepod.com/tips    FIND ME ON SOCIAL MEDIA: Instagram  Facebook  YouTube         

What exactly is medical gaslighting, and why do so many patients feel dismissed? Dr. Efrat LaMandre, PhD - nationally recognized nurse practitioner, educator, and healthcare disruptor - breaks it down. She explains how both doctors and patients are indoctrinated, why symptoms matter even when labs look “normal,” and what practical steps you can take to build the right care team so you can truly heal. DR. E'S SOCIAL MEDIA LINKS Instagram: www.instagram.com/drefratlamandre Facebook: www.facebook.com/drefratlamandre TikTok: www.tiktok.com/@drefratlamandre YouTube: www.youtube.com/@DrEfratLaMandre Website: www.drefratlamandre.com RESOURCES & LINKS Naturepedic: Code FUNC15 at 

Is Tylenol really safe?With all the dramatic discussions online about acetaminophen, autism, and potential side effects (that include liver failure risks), my clients have been asking my opinion. The truth is somewhere in the middle because, as with anything – over-the-counter medications like this, herbs or even nutritional supplements – there are pros and cons.Nothing is risk–free.In this episode, I'm breaking down what acetaminophen does in your body, what it depletes (super important!), stats on side effects, and what to consider before reaching for it—plus some supportive options and cleaner alternatives.⭐️Mentioned in This Episode:- See all the references

The cause of autism revealed—is it Tylenol? Is there an ideal probiotic for Crohn's Disease? Treating constipation by modifying the microbiome with botanicals; ACTION ALERT: If Congress has its way, 95% of natural hemp products with CBD/THC may be banned by year's end! The popular diet that reverses psoriasis; A daily habit that could save you from chronic back pain.

Have you tried maca root for perimenopause, menopause, manopause (low T), adrenal fatigue, or hormone imbalances and felt like it didn't work—or even made things worse? While it's often marketed as a universal hormone balancer, not all maca is created equal. Different types of maca root affect the body in very different ways, so using the wrong kind can actually worsen symptoms triggering anxiety, acne, or energy crashes.In this episode, Dr. Deanna Minich, PhD—nutrition scientist and educator —returns to unpack the science behind maca's many forms. With over 20 years of experience in both academia and the natural health industry, Dr. Minich shares…

Content curated for dermatologists and skin deep HCPs – on Psoriasis, CLE, vasculitis, HS and dermatology drugs use, efficacy and side effects and more.  Features Dr. Jack Cush, Editor at RheumNow.com. SHOW NOTES: 1. SMILE Study: A randomized, placebo-controlled trial of hydroxychloroquine in incomplete lupus  https://t.co/NnrA8ohiGX 2. Equal Safety of JAK Inhibitors and TNF Inhibitors in H2H IMID trials JAMA systematic review.  https://t.co/HI1KBKZiXR 3. SMART study - Single vs. Split Dose Methotrexate  https://t.co/lizsrtVHwf 4. Vegan diets don't work in RA - Metanalysis of 7 studies https://t.co/jeh6gN5Byg 5. No association between IL-17 inhibitors & MACEs (vs TNFi Rx)  https://t.co/fJuPFYKnSr https://t.co/Vscnsq0DTA 6. Successful Phase 3 UP-AA Trial evaluating Upadacitinib in Alopecia Areata (AA) https://t.co/8p1FvJx0s0 7. Anifrolumab effective & safe in refractory Cutaneous LE - OL Study in 15 CLE https://t.co/umEYz0XDyt 8. "Never doubt that a small group of thoughtful, committed citizens can change the world; indeed, it's the only thing that ever has." - Margaret Mead https://t.co/OFGN223bPa

Use the code ROOT at check-out for 10% off Rayvi: https://rayvishop.com/ In this episode of To The Root, Robyn Spangler speaks with Clear Skin Lab client Kolby about her 20-year struggle with psoriasis and cystic acne. After years of conventional treatments—including Accutane, birth control, and countless topicals—Kolby found that these approaches offered only temporary relief. Her story highlights the turning point of transitioning from conventional dermatology to a functional, root-cause approach. Through comprehensive lab testing, mineral balance, targeted supplementation, and nutrition strategies tailored to her lifestyle, Kolby began to see significant improvements in her skin health. Kolby also shares insights into the emotional side of chronic skin conditions, the importance of proper expectation-setting, and how she learned to heal without overly restrictive diets or unsustainable supplement routines. Her journey is a powerful reminder that skin healing requires both the right data and the right support. Listen now! Get root cause answers with data - check out our Acne Labs Panel!Highlights:Kolby's early experiences with psoriasis and cystic acneWhy conventional treatments failed to deliver long-term resultsThe role of functional testing in uncovering hidden root causesHow mineral support and individualized supplementation made a differenceReframing nutrition: moving away from strict elimination dietsBuilding realistic expectations and confidence during the healing processConnect with Robyn:Instagram: @nutritionbyrobyn Website: https://www.theclearskinlab.com

Psoriasis and Eczema FIXED by Removing This Hidden Trigger! | Podcast #462 FREE Functional Medicine Consult: http://www.justinhealth.com/free-consultation Are you tired of endless creams and medications for your psoriasis or eczema—with no real long-term results? It's time to stop chasing symptoms and start fixing the root cause. In this episode, Dr. Justin Marchegiani explains how gut inflammation, leaky gut, and immune dysregulation are often the real triggers behind chronic skin issues like eczema and psoriasis. You'll learn how gluten, processed foods, infections, and even stress can sabotage your skin health by damaging your gut lining and over-activating your immune system. Discover the gut-skin connection, the best functional medicine tests to uncover hidden triggers, and the most effective natural protocols for healing your skin from the inside out. ✅ What You'll Learn: The most common hidden root cause of psoriasis and eczema (and why most doctors miss it) How leaky gut and food sensitivities drive chronic skin inflammation The gut-skin axis explained simply—how your gut affects your skin Top inflammatory foods to eliminate for clearer skin Natural solutions, supplements, and protocols that support skin healing and reduce flare-ups

Is forgetfulness just a normal part of aging—or could it be the early signs of dementia?After watching a loved one slowly lose their ability to speak, eat, and remember who they were, I knew I had to find answers. That's why I sat down with Dr. Heather Sandison, ND, to explore the truth about Alzheimer's and dementia—and what you can do to protect your brain long before symptoms take hold.We're talking early warning signs, testing to understand your dementia risk, hidden inflammatory brain triggers, dementia genes, and science-backed steps to get ahead of cognitive decline.Yes, you can do something about this – and it has to start long before you've got symptoms!

Ever notice a stubborn white coating on your tongue that just won't go away—no matter how much you brush or scrape? It might seem harmless, but it could be your body's way of saying something deeper is going on. Because what's happening in your mouth can reflect hidden imbalances in your gut—and even impact your skin, energy, and brain fog. In this episode, we'll dive into candida overgrowth connection with your mouth, how to look for oral thrush (aka. candida tongue), and who to ask for help!⭐️Mentioned in This Episode:- See all the resources